Nigeria

Section divider

We’ve reached millions of Nigerian women, men and children since 1978.

  • Jhpiego-trained skilled birth attendants supervised more than 2.3 million antenatal care visits and 533,000 institutional deliveries.
  • HIV testing services were provided to more than 540,000 people, 4.9% of which were identified as HIV-positive. Among those identified as HIV-positive, 99% were linked to same-day care and treatment.
  • Jhpiego’s technical assistance has resulted in development of up-to-date national guidelines on HIV testing services to permit recency testing and other novel case-finding approaches, including HIV self-testing, partner notification services (index testing) and dual HIV/syphilis rapid diagnostic testing.
  • Jhpiego pioneered an approach to link community-based volunteers with health centers to address malaria in pregnancy in Akwa Ibom State, increasing the percentage of women taking two doses of sulfadoxine-pyrimethamine for malaria prevention by 66%.Since 2012, more than 178,000 pregnant women have received intermittent treatment of malaria under direct observation, thereby reducing the high risks that malaria poses to pregnant women  and their newborns.

Our Work in Nigeria

RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming, and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. RISE is currently active in several countries, including Nigeria.

With funding from the U.S. Agency for International Development (USAID), Jhpiego is working in select countries, including Nigeria, to address the COVID-19 pandemic. In Nigeria, RISE is supporting the Government of Nigeria in multiple states to operationalize and support Emergency Operations Centers to coordinate management of COVID-19 response across each state.

Funded by the U.S. Centers for Disease Control and Prevention (CDC), this five-year project builds upon activities funded by CDC to support Global Health Security through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health and other institutions. With an initial emphasis on addressing the COVID-19 pandemic, the project is supporting countries—including Nigeria—as well as regional work in West Africa and South America to improve prevention of avoidable epidemics, including naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens; improve ability to detect threats early; and respond rapidly and effectively to public health threats of international concern. The project is being implemented by a Jhpiego-led consortium that includes the Johns Hopkins Center for Health Security, the Johns Hopkins University Applied Physics Laboratory, Global Scientific Solutions for Health, and Johns Hopkins University Center for Global Health.

This award, funded by Gavi, the Vaccine Alliance, is enabling Jhpiego to provide technical assistance to ministries of health in 15 countries across Africa and Asia for the planning and introduction of COVID-19 vaccines. Under this effort, Jhpiego supports the ministries of health in a number of countries, including Nigeria, to introduce COVID-19 vaccines. Support includes development of sound, locally relevant, globally compliant readiness assessments using the COVID-19 Vaccine Country Readiness Assessment Tool. This work is being implemented in conjunction with a subpartner, the International Vaccine Access Center of the Johns Hopkins School of Public Health.

Funded by Unitaid, STAR Phase 3 is being implemented by a consortium of partners referred to as the STAR Core team, which includes consortium lead PSI, PATH and Jhpiego, as well as the International Labor Organisation with technical oversight by the World Health Organization. Implemented in seven countries (Cameroon, India, Indonesia, Mozambique, Nigeria, Tanzania and Uganda), STAR Phase 3 is focused on addressing market barriers to HIV self-testing rollout and establishing the structures, systems and oversight mechanisms necessary for the long-term sustainability of HIV self-testing. In Nigeria, where Jhpiego is the lead partner, STAR Phase 3 activities include facilitating the distribution of more than 260,000 HIV self-test kits, in complement with Jhpiego’s work though the RISE initiative described above.

Jhpiego serves as a core partner on the Palladium-led Integrated Health Program, the U.S. Agency for International Development’s main program for primary health care (PHC) in Nigeria. The overall objectives are to strengthen systems supporting PHC services, improve access to PHC services and increase the quality of PHC services. The program is expected to contribute to reductions in child and maternal morbidity and mortality in up to five target states, and to increase the capacity of health systems (public and private) to sustainably support high-quality PHC services. Jhpiego’s role is to support the program’s technical areas of reproductive health, family planning, and maternal and newborn health, including providing support for training and mentoring of providers, while also contributing to the quality assurance and quality improvement aspects of the program.

Jhpiego is working with the Ibadan Urban Flood Management Project to minimize the project’s potential risks of sexual exploitation, abuse and other forms of gender-based violence (GBV). The Government of Nigeria and the World Bank, who fund the project, recognize that the influx of construction workers into already-destabilized communities within infrastructure project areas can lead to an increase in GBV, in both public and private places. Changes in power dynamics within communities heighten the risk for trafficking of women for sex work, abuse of minors and forced marriage. Jhpiego’s role is to minimize the project’s potential risks of sexual exploitation and GBV by mapping available services for survivors and developing referral pathways. Secondary activities include conducting an assessment of the quality and accessibility of the mapped services, making recommendations for their improvement and developing a forum to share information and results with project stakeholders. The Government of Nigeria and the World Bank are also supporting Jhpiego under a second award to carry out a similar scope of work for construction projects with the North East Development Commission in the states of Borno, Adamawa and Yobe in Northeast Nigeria.

Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here: www.tiptopmalaria.org.

This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Nigeria.

Funded by MSD, the RICOM3 project is focused on reducing maternal morbidity and mortality from diabetes, hypertension and other indirect causes. RICOM3 is testing a quality of care model to improve prevention, early detection and management of noncommunicable diseases and risk factors in women of reproductive age across the maternal and reproductive health care continuum. This project is implemented by Jhpiego with consortium partners mDoc and the Health Strategy and Delivery Foundation.

 

 

 

 

Moving Integrated, Quality Maternal, Newborn and Child Health and Family Planning and Reproductive Health Services to Scale (MOMENTUM) is a suite of projects, funded by the U.S. Agency for International Development, that aims to accelerate reductions in maternal, newborn and child mortality and morbidity in high-burden countries by increasing host country commitment and capacity to provide high-quality, integrated health care. Each of the projects has a specific focus area; together they provide a comprehensive, flexible package of support for countries as they overcome context-specific health challenges towards sustainable development. The five-year, Jhpiego-led MOMENTUM Country and Global Leadership project focuses on: 1) providing targeted technical and capacity development assistance to our missions, partner countries and local organizations; and 2) contributing to global technical leadership and policy dialogue for improved maternal, newborn and child health, voluntary family planning and reproductive health outcomes. Jhpiego’s 12 sub-partners under this project are: Save the Children, Johns Hopkins University International Vaccine Access Center, The Manoff Group, Quicksand, Matchboxology, BAO Systems, Avenir Health, McKinsey and Company, PACT, Institute for Healthcare Improvement, Christian Connections for International Health and Ubora Quality Institute.

In Nigeria, the project is focused on gender-based violence (including intimate partner violence and sexual violence), child early and forced marriage, and early adoption of FP. Interventions are designed to deliver high-quality services that address gender-based violence and child early and forced marriage, as well as voluntary family planning and reproductive health care responsive to population needs.

With funding from the Nigeria for Women Project, Jhpiego is mapping gender-based violence (GBV) services and developing referral pathways for survivors of GBV in the states of Niger, Taraba and Kebbi. The goal of this work—which is contracted through a larger program supported by the World Bank to create an enabling environment for women—is to minimize the potential risks of sexual exploitation, abuse and other forms of GBV. Secondary activities include an assessment of the quality and accessibility of the mapped services, recommendations for their improvement, and development of a forum for sharing information and results with project stakeholders. The project also supports design and delivery of training modules on GBV risk mitigation.